Literature DB >> 35081574

Grading Pancreatic Neuroendocrine Tumors via Endoscopic Ultrasound-guided Fine Needle Aspiration: A Multi-Institutional Study.

Ammar A Javed1, Alessandra Pulvirenti, Samrah Razi, Jian Zheng, Theodoros Michelakos, Yurie Sekigami, Elizabeth Thompson, David S Klimstra, Vikram Deshpande, Aatur D Singhi, Matthew J Weiss, Christopher L Wolfgang, John L Cameron, Alice C Wei, Amer H Zureikat, Cristina R Ferrone, Jin He.   

Abstract

OBJECTIVES: To identify factors associated with concordance between World Health Organization (WHO) grade on cytological analysis (c-grade) and histopathological analysis (h-grade) of surgical specimen in patients with PanNETs and examine trends in utilization and accuracy of EUS-FNA in preoperatively predicting grade.
BACKGROUND: WHO grading system is prognostic in pancreatic neuroendocrine tumors (PanNETs). The concordance between c-grade and h-grade is reported to be between 60% and 80%.
METHODS: A multicenter retrospective study was performed on patients undergoing resection for PanNETs at four high-volume centers. Patients with functional or syndrome-associated tumors, and those receiving neoadjuvant therapy were excluded. Factors associated with concordance between c-grade and h-grade and trends of utilization of EUS-FNA were assessed.
RESULTS: Of 1,336 patients included, 682 (51.1%) underwent EUS-FNA; 567 (83.1%) were diagnostic of PanNETs and WHO-grade was reported for 293 (51.7%) patients. The concordance between c-grade and h-grade was 78.2% with moderate inter-rater agreement (Kc=0.48,p<0.001). Significantly higher rates of concordance were observed in patients with smaller tumors (<2 vs. ≥2 cm, 88.9% vs. 72.7%,p=0.001). Highest concordance (97.9%) was observed in patients with small tumors undergoing assessment between 2015-2019 with near-perfect inter-rater agreement (Kc=0.88,p<0.001)An increase in the utilization of EUS-FNA (46.7% to 62.1%) was observed over the last 2 decades (p<0.001). EUS-FNA was more frequently diagnostic of PanNETs (p<0.001), and WHO-grade was more frequently reported (<0.001). However, concordance between c-grade and h-grade did not change significantly (p=0.056).
CONCLUSION: Recently, a trend towards increasing utilization and improved diagnostic accuracy of EUS-FNA has been observed in PanNETs. Concordance between c-grade and h-grade is associated with tumor size with near-perfect agreement when assessing PanNETs >2 cm in size.
Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Year:  2022        PMID: 35081574      PMCID: PMC9364076          DOI: 10.1097/SLA.0000000000005390

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   13.787


  30 in total

1.  Cytological Ki-67 in pancreatic endocrine tumours: an opportunity for pre-operative grading.

Authors:  Cecilia Piani; Giulia M Franchi; Chiara Cappelletti; Marina Scavini; Luca Albarello; Alessandro Zerbi; Paolo Giorgio Arcidiacono; Emanuele Bosi; Marco F Manzoni
Journal:  Endocr Relat Cancer       Date:  2008-03       Impact factor: 5.678

2.  Endoscopic ultrasound-guided fine-needle aspiration for the diagnosis and grading of pancreatic neuroendocrine tumors: a retrospective analysis of 110 cases.

Authors:  Salvatore Paiella; Luca Landoni; Roberta Rota; Matteo Valenti; Giovanni Elio; Stefano Francesco Crinò; Erminia Manfrin; Alice Parisi; Sara Cingarlini; Mirko D'Onofrio; Aldo Scarpa; Rita Teresa Lawlor; Laura Bernardoni; Paola Capelli; Chiara Nessi; Marco Miotto; Armando Gabbrielli; Claudio Bassi; Roberto Salvia
Journal:  Endoscopy       Date:  2020-06-04       Impact factor: 10.093

Review 3.  Endoscopic ultrasound in the localisation of pancreatic islet cell tumours.

Authors:  A M McLean; P D Fairclough
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2005-06       Impact factor: 4.690

4.  Pancreatic neuroendocrine tumors: accurate grading with Ki-67 index on fine-needle aspiration specimens using the WHO 2010/ENETS criteria.

Authors:  Jessica M Farrell; Judy C Pang; Grace E Kim; Z Laura Tabatabai
Journal:  Cancer Cytopathol       Date:  2014-07-09       Impact factor: 5.284

5.  Ki-67 grading of nonfunctioning pancreatic neuroendocrine tumors on histologic samples obtained by EUS-guided fine-needle tissue acquisition: a prospective study.

Authors:  Alberto Larghi; Gabriele Capurso; Antonella Carnuccio; Riccardo Ricci; Sergio Alfieri; Domenico Galasso; Francesca Lugli; Antonio Bianchi; Francesco Panzuto; Laura De Marinis; Massimo Falconi; Gianfranco Delle Fave; Giovanni Battista Doglietto; Guido Costamagna; Guido Rindi
Journal:  Gastrointest Endosc       Date:  2012-09       Impact factor: 9.427

6.  Can pancreatic neuroendocrine tumour biopsy accurately determine pathological characteristics?

Authors:  Vinciane Rebours; Jacqueline Cordova; Anne Couvelard; Monique Fabre; Laurent Palazzo; Marie Pierre Vullierme; Olivia Hentic; Alain Sauvanet; Alain Aubert; Pierre Bedossa; Philippe Ruszniewski
Journal:  Dig Liver Dis       Date:  2015-06-20       Impact factor: 4.088

7.  Grading of pancreatic neuroendocrine tumors on endoscopic ultrasound-guided fine-needle aspiration using Ki-67 index and 2017 World Health Organization criteria: An analysis of 32 cases.

Authors:  Sweety Kalantri; Pooja Bakshi; Kusum Verma
Journal:  Cytojournal       Date:  2020-09-18       Impact factor: 2.091

8.  Evaluation of Ki-67 index in EUS-FNA specimens for the assessment of malignancy risk in pancreatic neuroendocrine tumors.

Authors:  Toshiyuki Hasegawa; Kenji Yamao; Susumu Hijioka; Vikram Bhatia; Nobumasa Mizuno; Kazuo Hara; Hiroshi Imaoka; Yasumasa Niwa; Masahiro Tajika; Shinya Kondo; Tutomu Tanaka; Yasuhiro Shimizu; Taira Kinoshita; Takuhiro Kohsaki; Isao Nishimori; Shinji Iwasaki; Toshiji Saibara; Waki Hosoda; Yasushi Yatabe
Journal:  Endoscopy       Date:  2013-11-11       Impact factor: 10.093

9.  The Role of Endoscopic Ultrasound-Guided Ki67 in the Management of Non-Functioning Pancreatic Neuroendocrine Tumors.

Authors:  YongYan Cui; Lauren G Khanna; Anjali Saqi; John P Crapanzano; James M Mitchell; Amrita Sethi; Tamas A Gonda; Michael D Kluger; Beth A Schrope; John Allendorf; John A Chabot; John M Poneros
Journal:  Clin Endosc       Date:  2019-07-15

10.  Molecular Genomic Assessment Using a Blood-based mRNA Signature (NETest) is Cost-effective and Predicts Neuroendocrine Tumor Recurrence With 94% Accuracy.

Authors:  Irvin M Modlin; Mark Kidd; Andrea Frilling; Massimo Falconi; Pier Luigi Filosso; Anna Malczewska; Alexandra Kitz
Journal:  Ann Surg       Date:  2021-09-01       Impact factor: 13.787

View more
  1 in total

1.  Endoscopic ultrasound-guided side-fenestrated needle biopsy sampling is sensitive for pancreatic neuroendocrine tumors but inadequate for tumor grading: a prospective study.

Authors:  Alexander Appelstrand; Fredrik Bergstedt; Anna-Karin Elf; Henrik Fagman; Per Hedenström
Journal:  Sci Rep       Date:  2022-04-08       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.